Genscript Biotech Corp Class H (SEHK:1548)

APAC company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - 1548

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - 1548

  • Market CapHKD0.000m
  • SymbolSEHK:1548
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINKYG3825B1059

Company Profile

GenScript Biotech is a China-based provider of life science research services and products. Founded in 2002, GenScript’s core business is gene synthesis, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. In 2014, GenScript was the largest global provider of gene synthesis, with 25% market share. In addition to its traditional business of providing gene synthesis and other life science services and products, it is the sole owner of a prerevenue cell therapy biotech company called Legend Biotech, whose key pipeline asset is a BCMA-targeting CAR-T treatment for multiple myeloma. We estimate that more than two thirds of GenScript’s valuation is from Legend.Genscript Biotech Corp an investment holding firm. It is involved in the business of fundamental life sciences research, translational biomedical research and early stage pharmaceutical development.

Latest 1548 news

Currently there for this company. Visit our news hub for other news .